|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.12 USD | +28.00% |
|
+29.29% | -2.85% |
| May. 07 | Bioventus Inc. Revises Earnings Guidance for the Full-Year 2024 | CI |
| May. 07 | Bioventus Inc. Reports Earnings Results for the First Quarter Ended March 30, 2024 | CI |
Bioventus Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 512.35 million compared to USD 512.12 million a year ago. Net loss was USD 156.23 million compared to USD 158.7 million a year ago.
Basic loss per share from continuing operations was USD 1.54 compared to USD 1.7 a year ago. Basic loss per share was USD 2.49 compared to USD 2.59 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -2.85% | 327M | |
| +73.43% | 12.41B | |
| -16.51% | 8.14B | |
| +16.03% | 7.2B | |
| +4.95% | 5.93B | |
| +13.07% | 5.43B | |
| +36.46% | 4.89B | |
| -19.82% | 4.09B | |
| -34.06% | 2.49B | |
| +1.24% | 2.04B |
BIOVENTUS INC. 